PHARMALA BIOTECH HLDG INC (MDXXF) analyst actions
Rating and price-target actions on MDXXF in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the MDXXF overview →
1 measured MDXXF analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| PharmAla Signs Agreement and Initiates R&D with Corealis Pharma for GMP Manufacturing of its patented ALA-002 Drug Product | Press release | +0.00% | +0.00% |
Keep exploring
More MDXXF: earnings → · SEC filings → · MDXXF overview →